Substance Use Disorders Practice Questions

Q: Which of the following statements is most true regarding Korsakoff syndrome?

Chronic amnestic syndrome is a feature.. ***Chronic amnestic syndrome is a feature.*** - **Chronic amnestic syndrome** is THE DEFINING feature of Korsakoff syndrome, making this the most true statement. - The hallmark clinical features include **severe anterograde amnesia** (inability to form new memories), **variable retrograde amnesia**, and **confabulation**. - **General intelligence, social skills, and executive functions** are typically preserved, distinguishing it from dementia. - This amnestic syndrome is present regardless of the etiology and is the primary diagnostic criterion. *Can be seen in chronic alcoholics.* - This statement is true but less specific than the correct answer. - **Chronic alcoholism** is the most common cause of Korsakoff syndrome due to **thiamine (vitamin B1) deficiency** from poor nutrition and impaired absorption. - However, Korsakoff syndrome can also result from other causes of thiamine deficiency (hyperemesis gravidarum, malnutrition, gastrointestinal malabsorption, malignancy). - The association with alcoholism is about etiology, not the defining feature of the syndrome itself. *Intellectual decline is present.* - This is misleading and largely incorrect. - Unlike dementia, Korsakoff syndrome shows **preserved general intelligence (IQ)** and intact cognitive abilities outside of memory. - Patients can maintain normal conversation, reasoning, and social skills despite profound memory deficits. - The cognitive impairment is specifically related to **memory encoding and retrieval**, not generalized intellectual decline. *None of the options.* - This is incorrect as multiple statements are true, particularly the statement about chronic amnestic syndrome being a feature.

Q: Which drug is most commonly used worldwide in maintenance treatment for opioid dependence?

Methadone. ***Methadone (Correct Answer)***- It is a **long-acting opioid agonist** that helps reduce cravings and withdrawal symptoms associated with opioid dependence, making it highly effective for maintenance treatment [2].- Its widespread availability and established efficacy in reducing illicit opioid use, crime, and disease transmission contribute to its global prevalence [1].- Methadone acts on **μ-opioid receptors** [2] and has a long half-life (24-36 hours), allowing once-daily dosing in maintenance therapy.*Disulfiram (Incorrect)*- This drug is primarily used in the management of **alcohol dependence** by causing unpleasant reactions when alcohol is consumed (inhibits aldehyde dehydrogenase) [3].- It has no role in the treatment of opioid dependence, as its mechanism of action is unrelated to opioid receptors.*Naltrexone (Incorrect)*- While used for opioid dependence, **naltrexone** is an **opioid antagonist** that blocks the effects of opioids [4].- Its use requires complete detoxification from opioids before initiation to avoid precipitated withdrawal, which can be a barrier to its common use in maintenance compared to methadone [1].- Less commonly used globally compared to methadone for maintenance treatment.*Imipramine (Incorrect)*- **Imipramine** is a **tricyclic antidepressant** primarily used to treat depression and some anxiety disorders.- It does not have any direct pharmacological action on opioid receptors and is not used in the treatment of opioid dependence.

Q: Which of the following is NOT a characteristic feature of delirium tremens?

Severe depression. ***Severe depression*** - While mood disturbances can occur with alcohol withdrawal, **severe depression** is not a hallmark or defining feature of **delirium tremens (DTs)** itself. - DTs primarily manifest as severe autonomic hyperactivity, altered mental status, and perceptual disturbances. *Hallucination* - **Hallucinations**, particularly **visual** (e.g., seeing insects or small animals), are a classic and common feature of delirium tremens. - These perceptual disturbances contribute significantly to the agitated and disoriented state of patients experiencing DTs. *Extreme anxiety* - **Extreme anxiety**, agitation, and fear are very common in delirium tremens due to the heightened state of arousal and terrifying hallucinations. - This **hyperarousal** is a direct result of the severe autonomic dysregulation. *Delusion* - **Delusions**, often **paranoid** or referring to being persecuted, are frequently observed in patients with delirium tremens. - These fixed, false beliefs contribute to the patient's confusion, fear, and sometimes aggressive behavior.

Q: Headache, behavioral changes, schizophrenia-like psychosis, visual hallucinations, and paranoid symptoms are seen in intoxication or abuse of?

Amphetamines. ***Amphetamines*** - **Amphetamine intoxication** can cause a range of neuropsychiatric symptoms, including **headache**, **behavioral changes**, **paranoia**, and **schizophrenia-like psychosis** due to excessive dopamine release. - **Visual hallucinations** are also a common feature, reflecting severe neurochemical imbalance in the brain. *Cocaine* - While cocaine intoxication can cause **paranoia** and **psychosis**, **headache** and severe **schizophrenia-like psychosis** with prominent visual hallucinations are more characteristic of chronic amphetamine abuse. - Cocaine's effects are typically shorter-acting and often involve increased heart rate and blood pressure, with CNS effects that may not be as prolonged or severe as amphetamines in terms of psychosis. *Heroin* - Heroin is an **opioid** that primarily causes central nervous system **depression**, leading to sedation, constricted pupils, and respiratory depression. - It is **not associated with headache, behavioral changes, or schizophrenia-like psychosis with hallucinations** as described in the question. - Opioid intoxication presents with the classic triad of CNS depression, miosis (pinpoint pupils), and respiratory depression. *Cannabis* - **Cannabis** can induce **psychotic symptoms** and paranoia in some individuals, especially with high doses or in predisposed individuals, but a full-blown **schizophrenia-like psychosis** with severe behavioral changes and visual hallucinations as described is not its typical presentation, and headache is not a defining feature of cannabis intoxication. - Its effects are more commonly associated with altered perception, euphoria, and impaired coordination.

Q: Which of the following drugs is not useful in the rehabilitation of alcoholic patients?

Rimonabant. Rimonabant - Rimonabant is an inverse agonist of the cannabinoid CB1 receptor that was used as an anti-obesity drug. [1] - It was withdrawn from the market due to significant psychiatric side effects, including depression and suicidal ideation. [1] - Rimonabant has absolutely no role in alcohol rehabilitation and is no longer available for clinical use. Acamprosate - Acamprosate is commonly used in alcohol rehabilitation to reduce alcohol cravings and promote abstinence in detoxified alcohol-dependent individuals. [2] - It is thought to act by restoring the balance between excitation and inhibition in the brain, particularly by modulating glutamate and GABA neurotransmission. - It is FDA-approved for maintenance of alcohol abstinence. Naltrexone - Naltrexone is an opioid receptor antagonist used to reduce alcohol craving and relapse by blocking the pleasurable effects of alcohol. [2], [3] - It is available in both oral and intramuscular long-acting injectable forms and is FDA-approved for alcohol use disorder. [3] - It can also be used for opioid use disorder. [3] Varenicline - Varenicline is a partial agonist of the nicotinic acetylcholine receptor and is primarily FDA-approved for smoking cessation. - Some research has explored its potential for reducing alcohol consumption due to its effects on reward pathways, though it is not FDA-approved for alcohol dependence. - Unlike rimonabant (which is withdrawn and has no role), varenicline has some supporting evidence in alcohol treatment, though it remains off-label use.

Q: Which substance is associated with the flashback phenomenon in the context of drug use?

LSD/Hallucinogens. ***LSD/Hallucinogens*** - **Flashback phenomenon** or **Hallucinogen Persisting Perception Disorder (HPPD)** is specifically associated with hallucinogens like **LSD**, causing re-experiencing of perceptual distortions long after drug cessation. - These episodes can be triggered by **stress** or **fatigue** and occur without recent drug use or underlying psychiatric disorders. *Cocaine* - Cocaine is a **stimulant** that blocks dopamine reuptake, causing euphoria and increased energy but not flashbacks. - Associated complications include **psychosis** and **paranoia**, but not the characteristic re-experiencing of perceptual distortions. *Amphetamine* - Another **stimulant** that increases dopamine and norepinephrine release, causing alertness and euphoria. - Can cause **amphetamine psychosis** with chronic use, but **flashback phenomenon** is not a recognized effect. *Heroin* - An **opioid** that binds to opioid receptors, producing euphoria followed by sedation and respiratory depression. - Associated with **addiction** and **overdose** risks, but not with flashback experiences or perceptual distortions.

Q: Which of the following is NOT a symptom of nicotine withdrawal?

Decreased appetite. ***Decreased appetite*** - Nicotine withdrawal typically leads to **increased appetite**, often resulting in weight gain after quitting smoking. - This is one of the most consistent symptoms of nicotine withdrawal, with individuals commonly craving snacks and sugary foods. - **Decreased appetite is NOT a symptom** of nicotine withdrawal; rather, the opposite occurs. *Irritability* - **Irritability** is a core DSM-5 criterion for nicotine withdrawal syndrome. - Individuals commonly experience **frustration, anger, and mood disturbances** as the body adjusts to the absence of nicotine. - This symptom typically peaks within the first week of cessation. *Difficulty concentrating* - **Cognitive impairment**, particularly difficulty concentrating, is a well-established symptom of nicotine withdrawal. - Users often report **impaired focus, decreased attention span, and mental fog** during the withdrawal period. - This reflects nicotine's effects on cholinergic neurotransmission in the brain. *Anxiety* - **Anxiety** is a prominent and distressing symptom during nicotine withdrawal. - Individuals experience **nervousness, restlessness, and heightened stress** as nicotine's anxiolytic effects wear off. - This symptom is recognized in both DSM-5 and ICD-11 diagnostic criteria for nicotine withdrawal.

Q: Symptomatic treatment is only required in withdrawal syndrome caused by:

Cannabis. ***Cannabis*** - **Cannabis withdrawal syndrome** is generally mild and non-life-threatening, **requiring only symptomatic management** for symptoms such as irritability, anxiety, sleep disturbances, and cravings. - Unlike withdrawal from opioids or alcohol, cannabis withdrawal does not present with severe physiological complications, seizures, or significant psychological distress requiring pharmacotherapy. - **Supportive care alone is sufficient** with reassurance, hydration, and rest. *Morphine* - **Opioid withdrawal** (e.g., from morphine) can be very distressing and painful, involving severe gastrointestinal symptoms, myalgia, and intense cravings. - **Requires pharmacological intervention** with medications like **methadone**, **buprenorphine**, or **clonidine** for symptom control and to prevent relapse. - Not merely symptomatic treatment. *Alcohol* - **Alcohol withdrawal syndrome** can be severe and life-threatening, potentially progressing to **delirium tremens** and seizures. - **Necessitates pharmacological treatment** with **benzodiazepines** (e.g., lorazepam, diazepam) to prevent serious complications. - Symptomatic treatment alone is inadequate and dangerous. *Cocaine* - **Cocaine withdrawal** is characterized by **dysphoria**, fatigue, hypersomnia, and intense cravings with high relapse risk. - While primarily managed with supportive care, **severe cases often require pharmacological intervention** for depression (antidepressants) and intense cravings. - Unlike cannabis, the psychological severity often necessitates more than just symptomatic management.

Q: Which of the following is a validated screening tool for alcohol use disorder?

All of the options. ***CAGE questionnaire and AUDIT*** - Both **CAGE** and **AUDIT** are widely validated screening tools specifically designed for alcohol use disorder [1]. - **CAGE** is a brief 4-item tool focusing on **C**ut down, **A**nnoyed, **G**uilty, and **E**ye-opener - ideal for quick screening in clinical settings [1]. - **AUDIT** (Alcohol Use Disorders Identification Test) is a comprehensive 10-item tool assessing consumption patterns, drinking behaviors, and alcohol-related problems. - AUDIT is considered the **gold standard** for screening and can assess risk levels and severity. *Why not SADQ alone?* - **SADQ** (Severity of Alcohol Dependence Questionnaire) is primarily a **severity assessment tool**, not a screening tool. - It is a 20-item instrument used to measure the **degree of alcohol dependence** in individuals already identified with alcohol problems. - While valuable for treatment planning, SADQ is more detailed and designed for assessment rather than initial screening [1]. - However, all three tools are validated and used in alcohol use disorder evaluation - CAGE and AUDIT for screening, SADQ for severity assessment.

Question 1

Which of the following statements is most true regarding Korsakoff syndrome?

Accepted Answer

Chronic amnestic syndrome is a feature.

Answer

Intellectual decline is present.

Answer

None of the options.

Answer

Can be seen in chronic alcoholics.

Question 2

Which drug is most commonly used worldwide in maintenance treatment for opioid dependence?

Accepted Answer

Methadone

Answer

Disulfiram

Answer

Naltrexone

Answer

Imipramine

Question 3

What is the drug of choice for treating delirium tremens?

Accepted Answer

Lorazepam

Answer

Phenytoin

Answer

Morphine

Answer

Diazepam

Question 4

Which of the following is NOT a characteristic feature of delirium tremens?

Accepted Answer

Severe depression

Answer

Extreme anxiety

Answer

Delusion

Answer

Hallucination

Question 5

Headache, behavioral changes, schizophrenia-like psychosis, visual hallucinations, and paranoid symptoms are seen in intoxication or abuse of?

Accepted Answer

Amphetamines

Answer

Heroin

Answer

Cocaine

Answer

Cannabis

Question 6

Which of the following drugs is not useful in the rehabilitation of alcoholic patients?

Accepted Answer

Rimonabant

Answer

Acamprosate

Answer

Naltrexone

Answer

Varenicline

Question 7

Which substance is associated with the flashback phenomenon in the context of drug use?

Accepted Answer

LSD/Hallucinogens

Answer

Cocaine

Answer

Amphetamine

Answer

Heroin

Question 8

Which of the following is NOT a symptom of nicotine withdrawal?

Accepted Answer

Decreased appetite

Answer

Irritability

Answer

Difficulty concentrating

Answer

Anxiety

Question 9

Symptomatic treatment is only required in withdrawal syndrome caused by:

Accepted Answer

Cannabis

Answer

Alcohol

Answer

Cocaine

Answer

Morphine

Question 10

Which of the following is a validated screening tool for alcohol use disorder?

Accepted Answer

All of the options

Answer

AUDIT

Answer

CAGE questionnaire

Answer

SADQ

Substance Use Disorders — MCQs

Substance Use Disorders — MCQs

On this page

Practice by Chapter

Want unlimited practice?